PLEASANTON, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging, a leader in innovative diagnostic medical device technology, is proud to announce it received FDA clearance for its next-generation Small Body Array for the Siemens Healthineers Magnetom Skyra and Vida series 3T MRI scanners. This new medical device is part of their industry-leading suite of MR coils designed to revolutionize the patient experience while enhancing efficiency in MRI scans and clinical diagnosis.

加利福尼亚州普莱森顿，2024年1月11日（环球通讯社）--InkSpace Imaging是创新诊断医疗设备技术的领导者，它骄傲地宣布，它为西门子Healthineers Magnetom Skyra和Vida系列3T MRI扫描仪的下一代小型身体阵列获得了FDA的批准。这种新型医疗设备是他们业界领先的MR线圈套件的一部分，旨在彻底改变患者体验，同时提高MRI扫描和临床诊断的效率。

The technologically advanced Small Body Array is huggable, lightweight, and flexible. It wraps around patients like a blanket, ensuring unparalleled image quality. The body contouring design optimizes the signal-to-noise ratio, which is crucial for detecting subtle abnormalities often missed by standard rigid, conventional coils.

技术先进的小型车身阵列体积大、重量轻、灵活。它像毯子一样包裹着患者，确保了无与伦比的图像质量。身体轮廓设计优化了信噪比，这对于检测标准刚性常规线圈经常遗漏的细微异常至关重要。

This leap in image quality means quicker and more accurate diagnoses, especially in complex cases. This design marks a dramatic shift from conventional coils, as InkSpace Imaging's coils are up to 80 percent lighter and provide a 10-40% faster throughput. The design of the Small Body Array is especially noteworthy for its flexibility which allows it to conform to a wide,e range of patient anatomies and sizes, significantly reducing scan times and minimizing the duration patients need to remain still.

这种图像质量的飞跃意味着更快，更准确的诊断，特别是在复杂的情况下。这种设计标志着传统线圈的巨大转变，因为InkSpace Imaging的线圈重量减轻了80%，吞吐量提高了10-40%。小型身体阵列的设计特别值得注意的是它的灵活性，它允许它符合广泛的患者解剖结构和尺寸，显着减少扫描时间并最大程度地减少患者需要保持静止的时间。

This adaptability ensures all patients receive optimal imaging experiences, enhanced patient comfort, and significantly benefits technologists by streamlining the imaging process due to its high coil element density. Dr. Peter Fischer, CEO of InkSpace Imaging, stated: 'The FDA clearance of InkSpace Imaging's Small Body Array marks a pivotal moment in MRI technology advancement.

这种适应性确保了所有患者获得最佳的成像体验，增强了患者的舒适度，并且由于其高线圈元件密度而简化了成像过程，从而使技术人员受益匪浅。InkSpace Imaging首席执行官彼得·菲舍尔（PeterFischer）博士表示：“美国食品药品管理局（FDA）批准InkSpace Imaging的小型人体阵列标志着MRI技术进步的关键时刻。

Our suite of MR coils is a game-changer, offering total freedom in coil positioning and han.

我们的MR线圈套件改变了游戏规则，提供了线圈定位和han的完全自由。